Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

2025 in review: high-impact articles from the <i>Journal of Medical Economics</i>.

Journal of medical economics·2026

Same author

2024 in review: high impact articles from the <i>Journal of Medical Economics</i>.

Journal of medical economics·2025

Same author

What to Expect in 2024: Important Health Economics and Outcomes Research (HEOR) Trends.

ClinicoEconomics and outcomes research : CEOR·2024

Same author

What to expect in 2024: important health economics and outcomes research (HEOR) trends.

Current medical research and opinion·2023

Same author

What to expect in 2024: important health economics and outcomes research (HEOR) trends.

Journal of medical economics·2023

Same author

<i>Journal of Medical Economics</i> in review: the best of 2021.

Journal of medical economics·2022

Search research articles

Related Experiment Video

Updated: Feb 2, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Immunotherapy Foreword 2018.

¹Future Science Group, Unitec House, 2 Albert Place, London N31QB, UK.

|November 27, 2018

Summary

This summary is machine-generated.

This foreword thanks readers and contributors for 2018, highlighting journal progress and anticipating future advancements in medical research for 2019.

Keywords:

JAK1 and JAK2 inhibitors asthma cancer checkpoint inhibitors immunotherapy tumor

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Related Experiment Videos

Last Updated: Feb 2, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

Area of Science:

Medical research and publishing.
Journal development and scientific communication.

Background:

The editorial office expresses gratitude to readers, editorial board members, peer reviewers, and authors for their support throughout 2018.
This foreword serves as a year-end review and a look ahead to the journal's trajectory.

Discussion:

Acknowledging the collaborative efforts that drive scientific progress.
Emphasizing the importance of continuous improvement in medical publishing.

Key Insights:

The journal experienced significant progress in 2018 due to strong community support.
Sustained readership and contributions are vital for advancing medical science.

Outlook:

Anticipating continued journal growth and impactful contributions in 2019.
Fostering new collaborations and scientific discoveries in the upcoming year.